Annual FCF
$22.49 M
+$107.05 M+126.59%
December 31, 2023
Summary
- As of February 20, 2025, ASMB annual free cash flow is $22.49 million, with the most recent change of +$107.05 million (+126.59%) on December 31, 2023.
- During the last 3 years, ASMB annual FCF has risen by +$87.67 million (+134.50%).
- ASMB annual FCF is now at all-time high.
Performance
ASMB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$15.24 M
+$1.87 M+10.94%
September 30, 2024
Summary
- As of February 20, 2025, ASMB quarterly free cash flow is -$15.24 million, with the most recent change of +$1.87 million (+10.94%) on September 30, 2024.
- Over the past year, ASMB quarterly FCF has dropped by -$88.82 million (-120.72%).
- ASMB quarterly FCF is now -120.72% below its all-time high of $73.58 million, reached on December 31, 2023.
Performance
ASMB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
$22.84 M
-$1.26 M-5.23%
September 30, 2024
Summary
- As of February 20, 2025, ASMB TTM free cash flow is $22.84 million, with the most recent change of -$1.26 million (-5.23%) on September 30, 2024.
- Over the past year, ASMB TTM FCF has increased by +$350.00 thousand (+1.56%).
- ASMB TTM FCF is now -17.07% below its all-time high of $27.54 million, reached on March 31, 2024.
Performance
ASMB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ASMB Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +126.6% | -120.7% | +1.6% |
| 3 y3 years | +134.5% | -120.7% | +1.6% |
| 5 y5 years | +134.4% | +25.8% | +126.7% |
ASMB Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.3% | -120.7% | +44.6% | -17.1% | +123.7% |
| 5 y | 5-year | at high | +123.3% | -120.7% | +58.1% | -17.1% | +121.9% |
| alltime | all time | at high | +123.3% | -120.7% | +58.1% | -17.1% | +121.9% |
Assembly Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.24 M(-10.9%) | $22.84 M(-5.2%) |
| Jun 2024 | - | -$17.12 M(-6.9%) | $24.10 M(-12.5%) |
| Mar 2024 | - | -$18.38 M(-125.0%) | $27.54 M(+22.5%) |
| Dec 2023 | $22.49 M(-126.6%) | $73.58 M(-626.1%) | $22.49 M(-132.0%) |
| Sep 2023 | - | -$13.98 M(+2.3%) | -$70.34 M(-7.8%) |
| Jun 2023 | - | -$13.68 M(-41.6%) | -$76.28 M(-5.2%) |
| Mar 2023 | - | -$23.43 M(+21.7%) | -$80.49 M(-4.8%) |
| Dec 2022 | -$84.56 M(-12.4%) | -$19.25 M(-3.4%) | -$84.56 M(-0.1%) |
| Sep 2022 | - | -$19.92 M(+11.4%) | -$84.69 M(+1.2%) |
| Jun 2022 | - | -$17.89 M(-35.0%) | -$83.65 M(-4.5%) |
| Mar 2022 | - | -$27.50 M(+41.9%) | -$87.57 M(-9.2%) |
| Dec 2021 | -$96.49 M(+48.0%) | -$19.38 M(+2.6%) | -$96.49 M(-7.3%) |
| Sep 2021 | - | -$18.88 M(-13.4%) | -$104.13 M(+39.6%) |
| Jun 2021 | - | -$21.81 M(-40.1%) | -$74.60 M(-2.2%) |
| Mar 2021 | - | -$36.42 M(+34.8%) | -$76.32 M(+17.1%) |
| Dec 2020 | -$65.18 M(-23.9%) | -$27.02 M(-353.8%) | -$65.18 M(+11.0%) |
| Sep 2020 | - | $10.65 M(-145.3%) | -$58.70 M(-33.3%) |
| Jun 2020 | - | -$23.52 M(-7.0%) | -$87.94 M(+2.9%) |
| Mar 2020 | - | -$25.28 M(+23.1%) | -$85.48 M(-0.2%) |
| Dec 2019 | -$85.62 M(+31.1%) | -$20.54 M(+10.5%) | -$85.62 M(+4.4%) |
| Sep 2019 | - | -$18.59 M(-11.7%) | -$82.02 M(+2.3%) |
| Jun 2019 | - | -$21.06 M(-17.2%) | -$80.14 M(+6.6%) |
| Mar 2019 | - | -$25.43 M(+50.1%) | -$75.19 M(+15.1%) |
| Dec 2018 | -$65.30 M(-6662.6%) | -$16.94 M(+1.3%) | -$65.30 M(+11.6%) |
| Sep 2018 | - | -$16.72 M(+3.9%) | -$58.49 M(+9.9%) |
| Jun 2018 | - | -$16.10 M(+3.6%) | -$53.23 M(+7.6%) |
| Mar 2018 | - | -$15.54 M(+53.4%) | -$49.49 M(-5073.8%) |
| Dec 2017 | $995.00 K(-102.8%) | -$10.13 M(-11.6%) | $995.00 K(-4161.2%) |
| Sep 2017 | - | -$11.46 M(-7.3%) | -$24.50 K(-100.7%) |
| Jun 2017 | - | -$12.36 M(-135.4%) | $3.54 M(-61.2%) |
| Mar 2017 | - | $34.94 M(-413.4%) | $9.13 M(-126.1%) |
| Dec 2016 | -$35.03 M | -$11.15 M(+41.2%) | -$35.03 M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | -$7.90 M(+16.7%) | -$29.34 M(+10.2%) |
| Jun 2016 | - | -$6.77 M(-26.5%) | -$26.63 M(+9.8%) |
| Mar 2016 | - | -$9.21 M(+68.6%) | -$24.26 M(+29.4%) |
| Dec 2015 | -$18.76 M(+24.0%) | -$5.47 M(+5.4%) | -$18.76 M(+10.2%) |
| Sep 2015 | - | -$5.19 M(+17.9%) | -$17.01 M(+8.2%) |
| Jun 2015 | - | -$4.40 M(+18.8%) | -$15.72 M(+15.2%) |
| Mar 2015 | - | -$3.70 M(-0.5%) | -$13.64 M(-9.8%) |
| Dec 2014 | -$15.12 M(-15.0%) | -$3.72 M(-4.4%) | -$15.12 M(-10.0%) |
| Sep 2014 | - | -$3.89 M(+67.8%) | -$16.79 M(-4.3%) |
| Jun 2014 | - | -$2.32 M(-55.3%) | -$17.56 M(-5.7%) |
| Mar 2014 | - | -$5.19 M(-3.8%) | -$18.62 M(+4.6%) |
| Dec 2013 | -$17.80 M(-16.7%) | -$5.39 M(+15.9%) | -$17.80 M(+15.0%) |
| Sep 2013 | - | -$4.66 M(+37.6%) | -$15.48 M(-3.9%) |
| Jun 2013 | - | -$3.38 M(-22.6%) | -$16.11 M(-18.1%) |
| Mar 2013 | - | -$4.37 M(+42.3%) | -$19.66 M(-8.0%) |
| Dec 2012 | -$21.38 M(-14.7%) | -$3.07 M(-41.9%) | -$21.38 M(-38.3%) |
| Sep 2012 | - | -$5.28 M(-23.9%) | -$34.64 M(+3.6%) |
| Jun 2012 | - | -$6.94 M(+13.9%) | -$33.43 M(+13.9%) |
| Mar 2012 | - | -$6.09 M(-62.7%) | -$29.34 M(+17.0%) |
| Dec 2011 | -$25.08 M(+381.0%) | -$16.33 M(+301.4%) | -$25.08 M(+151.6%) |
| Sep 2011 | - | -$4.07 M(+42.7%) | -$9.97 M(+44.1%) |
| Jun 2011 | - | -$2.85 M(+56.1%) | -$6.92 M(+31.8%) |
| Mar 2011 | - | -$1.83 M(+49.9%) | -$5.25 M(+0.7%) |
| Dec 2010 | -$5.21 M(+49.6%) | -$1.22 M(+19.3%) | -$5.21 M(-0.1%) |
| Sep 2010 | - | -$1.02 M(-13.7%) | -$5.22 M(+10.9%) |
| Jun 2010 | - | -$1.18 M(-33.9%) | -$4.71 M(+19.3%) |
| Mar 2010 | - | -$1.79 M(+46.3%) | -$3.94 M(+13.2%) |
| Dec 2009 | -$3.49 M(-16.0%) | -$1.22 M(+141.3%) | -$3.48 M(+54.2%) |
| Sep 2009 | - | -$507.20 K(+20.3%) | -$2.26 M(+28.9%) |
| Jun 2009 | - | -$421.60 K(-68.3%) | -$1.75 M(+31.7%) |
| Mar 2009 | - | -$1.33 M | -$1.33 M |
| Dec 2008 | -$4.15 M | - | - |
FAQ
- What is Assembly Biosciences annual free cash flow?
- What is the all time high annual FCF for Assembly Biosciences?
- What is Assembly Biosciences annual FCF year-on-year change?
- What is Assembly Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Assembly Biosciences?
- What is Assembly Biosciences quarterly FCF year-on-year change?
- What is Assembly Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Assembly Biosciences?
- What is Assembly Biosciences TTM FCF year-on-year change?
What is Assembly Biosciences annual free cash flow?
The current annual FCF of ASMB is $22.49 M
What is the all time high annual FCF for Assembly Biosciences?
Assembly Biosciences all-time high annual free cash flow is $22.49 M
What is Assembly Biosciences annual FCF year-on-year change?
Over the past year, ASMB annual free cash flow has changed by +$107.05 M (+126.59%)
What is Assembly Biosciences quarterly free cash flow?
The current quarterly FCF of ASMB is -$15.24 M
What is the all time high quarterly FCF for Assembly Biosciences?
Assembly Biosciences all-time high quarterly free cash flow is $73.58 M
What is Assembly Biosciences quarterly FCF year-on-year change?
Over the past year, ASMB quarterly free cash flow has changed by -$88.82 M (-120.72%)
What is Assembly Biosciences TTM free cash flow?
The current TTM FCF of ASMB is $22.84 M
What is the all time high TTM FCF for Assembly Biosciences?
Assembly Biosciences all-time high TTM free cash flow is $27.54 M
What is Assembly Biosciences TTM FCF year-on-year change?
Over the past year, ASMB TTM free cash flow has changed by +$350.00 K (+1.56%)